Harpoon Therapeutics Inc (DELISTED) (HARP:DL)
23.01
USD |
NASDAQ |
Mar 08, 16:00
Harpoon Therapeutics Profit Margin (Quarterly): -40.51% for Sept. 30, 2023
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Merck & Co., Inc. | 33.68% |
| Axonics Inc (DELISTED) | -0.02% |
| Johnson & Johnson | 21.47% |
| Boston Scientific Corp. | 14.91% |
| Ambrx Biopharma Inc (DELISTED) | -43.38K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -498.9% |
| Return on Assets | -43.72% |
| Return on Invested Capital | -498.9% |
| Operating Margin (Quarterly) | -272.9% |
| Return on Net Operating Assets | -200.1% |